Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (81-90 of 230) with videos related to

Pageof 23
Sort By:
Annals of Medicine|May 17, 2002
Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypesMing-Lin Liu, Kati Ylitalo, Juha Vakkilainen, et al.
Diabetes Care|November 6, 2008
Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyRussell Scott, Richard O'Brien, Greg Fulcher, et al.
Human Molecular Genetics|August 4, 2005
USF1 and dyslipidemias: converging evidence for a functional intronic variantJussi Naukkarinen, Massimiliano Gentile, Aino Soro-Paavonen, et al.
Diabetes Research and Clinical Practice|April 7, 2005
Lifestyle modification improves risk factors in type 2 diabetes relativesHilde K Brekke, Ragnhild A Lenner, Marja-Riitta Taskinen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetesElse H Johanson, Per-Anders Jansson, Lars Lönn, et al.
The American Journal of Cardiology|February 24, 2006
Association of carotid intima-media thickness with angiographic severity and extent of coronary artery diseaseMarit Granér, Marjut Varpula, Juhani Kahri, et al.
Atherosclerosis|July 31, 2018
Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trialMarja-Riitta Taskinen, Stefano Del Prato, Maja Bujas-Bobanovic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2024
Multi-omics characterization of lymphedema-induced adipose tissue resulting from breast cancer-related surgerySinem Karaman, Satu Lehti, Cheng Zhang, et al.
Atherosclerosis|March 16, 2010
Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndromeMaarten E Tushuizen, Petra J Pouwels, Saskia Bontemps, et al.
Metabolism: Clinical and Experimental|March 27, 2004
Lipoprotein metabolism in subjects with hepatic lipase deficiencyMarju Tilly-Kiesi, Ernst J Schaefer, Petteri Knudsen, et al.
Pageof 23

Showing results (81-90 of 230) with videos related to

Sort By:
Pageof 23
Annals of Medicine|May 17, 2002
Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypesMing-Lin Liu, Kati Ylitalo, Juha Vakkilainen, et al.
Diabetes Care|November 6, 2008
Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyRussell Scott, Richard O'Brien, Greg Fulcher, et al.
Human Molecular Genetics|August 4, 2005
USF1 and dyslipidemias: converging evidence for a functional intronic variantJussi Naukkarinen, Massimiliano Gentile, Aino Soro-Paavonen, et al.
Diabetes Research and Clinical Practice|April 7, 2005
Lifestyle modification improves risk factors in type 2 diabetes relativesHilde K Brekke, Ragnhild A Lenner, Marja-Riitta Taskinen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Fat distribution, lipid accumulation in the liver, and exercise capacity do not explain the insulin resistance in healthy males with a family history for type 2 diabetesElse H Johanson, Per-Anders Jansson, Lars Lönn, et al.
The American Journal of Cardiology|February 24, 2006
Association of carotid intima-media thickness with angiographic severity and extent of coronary artery diseaseMarit Granér, Marjut Varpula, Juhani Kahri, et al.
Atherosclerosis|July 31, 2018
Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trialMarja-Riitta Taskinen, Stefano Del Prato, Maja Bujas-Bobanovic, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2024
Multi-omics characterization of lymphedema-induced adipose tissue resulting from breast cancer-related surgerySinem Karaman, Satu Lehti, Cheng Zhang, et al.
Atherosclerosis|March 16, 2010
Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndromeMaarten E Tushuizen, Petra J Pouwels, Saskia Bontemps, et al.
Metabolism: Clinical and Experimental|March 27, 2004
Lipoprotein metabolism in subjects with hepatic lipase deficiencyMarju Tilly-Kiesi, Ernst J Schaefer, Petteri Knudsen, et al.
Pageof 23